Accessibility: Skip TopNav
Discovery of Ruxoprubart (NM8074)
Ruxoprubart was selected as a lead candidate for the treatment of Dermatomyositis (DM)
Format
JPEG
Quelle:
NovelMed Therapeutics Inc
Downloads
Originalgröße
Groß
Mittel
Klein